You are here

30-11-2016 | Image: FISH analysis performed by Sara Carloni, PhD: in situ staining of bacteria (in green) in the gut lumen. Nuclei stained in blue (dapi). 3 mins read

Gut bacteria could hold key to new treatments

An ERC-funded project has significantly increased understanding of the crucial role that microorganisms in the gut play in maintaining health. The findings have since led to a patent, as well as a follow-on project that could one day steer the way to new targeted treatments for diseases, including cancer.

22-07-2016 | Research picture: © Ivilin Stoianov, Marco Zorzi 5 mins read

Self-learning AI emulates the human brain

European researchers have designed brain-like artificial neural networks capable of numerical and spatial cognition and written language processing without any explicit training or pre-programming. Their work, based on the machine-learning approach of generative models, significantly advances the development of self-learning artificial intelligence, while also deepening understanding of human cognition.

02-05-2016 | Research picture: Melting Andean glaciers: view from water reservoir in Chivay (Peru), where water is precious and scarce. ©Astrid Stensrud 2 mins read

Addressing the crises of an ‘overheated’ world

Different responses might be given to global challenges. For example, how should the vanishing of a glacier be tackled? Prof. Thomas Eriksen aims to understand the economic, environmental and cultural transitions the world is going through and the responses created by local communities in order to offer valuable advice to our policymakers and leaders.

25-02-2016 | © picture 3 mins read

Effective targeted treatment for hairy cell leukaemia

An ERC-funded project is conducting groundbreaking research into a rare form of leukaemia, proving the effectiveness in patients of non-chemotherapy-based treatments that target the genetic cause of the disease. The Hairy Cell Leukemia project, launched by the Institute of Hematology at the University of Perugia in Italy with funding from the European Research Council, is one of the world’s foremost initiatives to develop a targeted therapy for hairy cell leukaemia (HCL), a rare form of blood cancer.